{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:42Z","timestamp":1787503002545,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Clonal hematopoiesis of indeterminate potential can be defined as genetic mutations that correlate in hematologic neoplasia such as myelodysplastic syndrome. Patients with cytopenia increasingly undergo molecular genetic tests of peripheral blood or bone marrow for diagnostic purposes. Recently, a new entity has been demarcated to lessen the risk of incorrect diagnoses of hematologic malignancies. This new entity is a potential precursor of myeloid diseases, analogous to monoclonal gammopathy of undetermined significance as a potential precursor of multiple myeloma.<\/jats:p>","DOI":"10.3390\/cancers14153663","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T03:21:16Z","timestamp":1658978476000},"page":"3663","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-3079","authenticated-orcid":false,"given":"Maroun","family":"Bou Zerdan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, New York, NY 10009, USA"},{"name":"Department of Hematology-Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33326, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Nasr","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saint-Joseph University, Beirut P.O. Box 100, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Saba","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saint-Joseph University, Beirut P.O. Box 100, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Meouchy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut P.O. Box 100, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Safi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut P.O. Box 100, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Allam","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Sciences, University of Balamand, Balamand P.O. Box 100, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenish","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, New York, NY 10009, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4641-2217","authenticated-orcid":false,"given":"Chakra P.","family":"Chaulagain","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33326, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/bloodadvances.2019000039","article-title":"In vivo dynamics of human hematopoietic stem cells: Novel concepts and future directions","volume":"3","author":"Scala","year":"2019","journal-title":"Blood Adv."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","article-title":"Population dynamics of normal human blood inferred from somatic mutations","volume":"561","author":"Shepherd","year":"2018","journal-title":"Nature"},{"key":"ref_3","first-page":"9","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-17-3044","article-title":"New insights from studies of clonal hematopoiesis","volume":"24","author":"Gibson","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_9","unstructured":"Sekeres, M.A., and Lindsley, R.C. (2021). Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Related Disorders of Clonal Hematopoiesis, UpToDate."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106787","DOI":"10.1016\/j.leukres.2022.106787","article-title":"Clonal Hematopoiesis: Molecular and Clinical Implications","volume":"113","author":"Kusne","year":"2022","journal-title":"Leuk. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exphem.2019.12.001","article-title":"Clonal hematopoiesis as a model for premalignant changes during aging","volume":"83","author":"Steensma","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chan, H.T., Chin, Y.M., Nakamura, Y., and Low, S.-K. (2020). Clonal hematopoiesis in liquid biopsy: From biological noise to valuable clinical implications. Cancers, 12.","DOI":"10.3390\/cancers12082277"},{"key":"ref_13","first-page":"e57509","article-title":"Rare event detection using error-corrected DNA and RNA sequencing","volume":"138","author":"Wong","year":"2018","journal-title":"J. Vis. Exp."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gde.2020.12.004","article-title":"Insights into clonal hematopoiesis and its relation to cancer risk","volume":"66","author":"Mitchell","year":"2021","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_15","first-page":"277","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_16","first-page":"1161","article-title":"Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals","volume":"135","author":"Wouters","year":"2020","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease","volume":"161","author":"Marnell","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/cas.15094","article-title":"Clonal hematopoiesis and associated diseases: A review of recent findings","volume":"112","author":"Asada","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"key":"ref_21","unstructured":"Hidalgo, R.A., Sengul, H., Steehouwer, M., van der Vorst, M., Veltman, J., Gilissen, C., and Hoischen, A. Ultra-sensitive detection of mosaic mutations in blood DNA of healthy individuals provides new insights into age-related clonal hematopoiesis. Proceedings of European Journal of Human Genetics."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.aau3879","article-title":"Somatic mutant clones colonize the human esophagus with age","volume":"362","author":"Martincorena","year":"2018","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06331-w","article-title":"High prevalence of focal and multi-focal somatic genetic variants in the human brain","volume":"9","author":"Keogh","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43141-021-00205-3","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases\u2014An updated systematic review","volume":"19","author":"Senguttuvan","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","article-title":"Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"105","author":"Arends","year":"2020","journal-title":"Haematologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood.2019001793","article-title":"Clonal hematopoiesis in elderly twins: Concordance, discordance, and mortality","volume":"135","author":"Hansen","year":"2020","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exphem.2019.12.005","article-title":"Environmental influences on clonal hematopoiesis","volume":"83","author":"King","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.2019003539","article-title":"Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL","volume":"135","author":"Eskelund","year":"2020","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41375-018-0047-7","article-title":"Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis","volume":"32","author":"Arends","year":"2018","journal-title":"Leukemia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","article-title":"Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN\u03b3 signaling","volume":"28","author":"Matatall","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rdc.2020.03.001","article-title":"Autoimmunity, clonal hematopoiesis, and myeloid neoplasms","volume":"46","author":"Bekele","year":"2020","journal-title":"Rheum. Dis. Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-26138-6","article-title":"Clonal hematopoiesis is associated with risk of severe Covid-19","volume":"12","author":"Bolton","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.seminhematol.2021.10.004","article-title":"Clonal hematopoiesis and VEXAS syndrome: Survival of the fittest clones?","volume":"58","author":"Kusne","year":"2020","journal-title":"Semin. Hematol"},{"key":"ref_37","first-page":"749","article-title":"What\u2019s new in the pathogenesis and treatment of therapy-related myeloid neoplasms","volume":"138","author":"Voso","year":"2021","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41409-020-01129-1","article-title":"ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation","volume":"56","author":"Jentzsch","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/bloodadvances.2021006652","article-title":"Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma","volume":"6","author":"Peres","year":"2022","journal-title":"Blood Adv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.seminoncol.2022.01.009","article-title":"The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma","volume":"49","author":"DeStefano","year":"2022","journal-title":"Semin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","article-title":"Prediction of acute myeloid leukaemia risk in healthy individuals","volume":"559","author":"Abelson","year":"2018","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3324\/haematol.2018.215269","article-title":"Clonal hematopoiesis and risk of acute myeloid leukemia","volume":"104","author":"Young","year":"2019","journal-title":"Haematologica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-22053-y","article-title":"Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt\/mTOR pathway","volume":"12","author":"Fujino","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17942-7","article-title":"Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGF\u03b21 as regulators of hematopoietic ageing","volume":"11","author":"Valletta","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_48","first-page":"2330","article-title":"Clonal hematopoiesis in myeloma: Root of all maladies!","volume":"135","author":"Neri","year":"2020","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/15\/3663\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:57:53Z","timestamp":1760140673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/15\/3663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":49,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["cancers14153663"],"URL":"https:\/\/doi.org\/10.3390\/cancers14153663","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]}}}